Kim Byung Jin, Han Ji Min, Kang Jung Gyu, Kim Bum Soo, Kang Jin Ho
a Division of Cardiology, Department of Medicine , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea.
b Center for Cohort Studies, Total Healthcare Center , Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , Seoul , Republic of Korea.
Blood Press. 2017 Oct;26(5):303-310. doi: 10.1080/08037051.2017.1344539. Epub 2017 Jun 23.
Previous studies showed inconsistent results concerning the relationship between chronic smoking and blood pressure. Most of the studies involved self-reported smoking status. This study was performed to evaluate the association of urinary cotinine or self-reported smoking status with hypertension and blood pressure in Korean adults.
Among individuals enrolled in the Kangbuk Samsung Health Study and Kangbuk Samsung Cohort Study, 167,868 participants (men, 55.7%; age, 37.5 ± 6.9 years) between 2011 and 2013 who had urinary cotinine measurements were included. Individuals with urinary cotinine levels ≥50 ng/mL were defined as cotinine-verified current smokers.
The prevalence of hypertension and cotinine-verified current smokers in the overall population was 6.8% and 22.7%, respectively (10.0% in men and 2.8% in women for hypertension: 37.7% in men and 3.9% in women for cotinine-verified current smokers). In a multivariate regression analysis adjusted for age, sex, body mass index, waist circumference, alcohol drinking, vigorous exercise, and diabetes, cotinine-verified current smoking was associated with lower prevalence of hypertension compared with cotinine-verified never smoking (OR[95% CI], 0.79 [0.75, 0.84]). Log-transformed cotinine levels and unobserved smoking were negatively associated with hypertension, respectively (0.96 [0.96, 0.97] and 0.55 [0.39, 0.79]). In a multivariate linear regression analysis, the cotinine-verified current smoking was inversely associated with systolic and diastolic blood pressure (BP) (regression coefficient[95% CI], -1.23[-1.39, -1.07] for systolic BP and -0.71 [-0.84, -0.58] for diastolic BP). In subgroup analyses according to sex, the inverse associations between cotinine-verified current smoking and hypertension were observed only in men.
This large observational study showed that cotinine-verified current smoking and unobserved smoking were inversely associated with hypertension in Korean adults, especially only in men.
先前的研究显示,慢性吸烟与血压之间的关系结果并不一致。大多数研究涉及自我报告的吸烟状况。本研究旨在评估韩国成年人尿可替宁或自我报告的吸烟状况与高血压及血压之间的关联。
在参与江北三星健康研究和江北三星队列研究的个体中,纳入了2011年至2013年间进行尿可替宁测量的167,868名参与者(男性占55.7%;年龄37.5±6.9岁)。尿可替宁水平≥50 ng/mL的个体被定义为经可替宁验证的当前吸烟者。
总体人群中高血压和经可替宁验证的当前吸烟者的患病率分别为6.8%和22.7%(高血压在男性中为10.0%,女性中为2.8%;经可替宁验证的当前吸烟者在男性中为37.7%,女性中为3.9%)。在对年龄、性别、体重指数、腰围、饮酒、剧烈运动和糖尿病进行调整的多变量回归分析中,与经可替宁验证的从不吸烟者相比,经可替宁验证的当前吸烟与较低的高血压患病率相关(比值比[95%置信区间],0.79[0.75, 0.84])。对数转换后的可替宁水平和未观察到的吸烟分别与高血压呈负相关(0.96[0.96, 0.97]和0.55[0.39, 0.79])。在多变量线性回归分析中,经可替宁验证的当前吸烟与收缩压和舒张压呈负相关(回归系数[95%置信区间],收缩压为-1.23[-1.39, -1.07],舒张压为-0.71[-0.84, -0.58])。在按性别进行的亚组分析中,仅在男性中观察到经可替宁验证的当前吸烟与高血压之间的负相关。
这项大型观察性研究表明,经可替宁验证的当前吸烟和未观察到的吸烟与韩国成年人的高血压呈负相关,尤其是仅在男性中。